Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|January 28, 2015
Nuclear osteopontin-c is a prognostic breast cancer markerK Zduniak, P Ziolkowski, C Ahlin, et al.
British Journal of Cancer|May 20, 2004
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature reviewJ Carlsson, H Nordgren, J Sjöström, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 7, 2022
Risk of coronary stenosis after adjuvant radiotherapy for breast cancerA-K Wennstig, H Garmo, L Wadsten, et al.
Cancer Research|August 2, 2001
p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predispositionP Vahteristo, A Tamminen, P Karvinen, et al.
British Journal of Cancer|December 4, 1998
Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrenceT Jahkola, T Toivonen, I Virtanen, et al.
Acta Oncologica (Stockholm, Sweden)|May 5, 1999
FEC mobilized stem cells for high-dose therapy in breast cancer patients. SB6 9401 Study GroupH Lindman, T Wiklund, H Holte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2013
Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancerR Fagerholm, K Sprott, T Heikkinen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2000
Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group RegisterC S Trovik, H C Bauer, T A Alvegård, et al.
European Journal of Clinical Microbiology|June 1, 1987
Multicentre evaluation of a direct coagglutination test for group A streptococciL Rudin, J Rotta, C Blomqvist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma GroupT A Alvegård, H Sigurdsson, H Mouridsen, et al.
Pageof 19